Granules India Ltd.

GRANULES

Market Cap
₹9,896 Cr.
P/E
25.04

Granules India Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
18.22%
3yr Average
19.82%
5yr Average
18.62%
Net Profit Margin
Latest
11.45%
3yr Average
13.13%
5yr Average
12.53%
ROCE
Latest
24.05%
3yr Average
24.36%
5yr Average
21.19%
Debt to Equity
Latest
0.37
3yr Average
0.39
5yr Average
0.46
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Europe DMF Filings (.)
      Source
    • Manufacturing Capacity - Metformin (MTPA)
      Source
    • Manufacturing Capacity - Ibuprofen (MTPA)
      Source
    • Total reactor capacity (kL)
      Source
    • Manufacturing Capacity - Paracetamol (MTPA)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Filed (.)
      Source
    • Number of ANDA's Approved (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Granules India Ltd.
    View the discussion on ValuePickr
    Granules 2.0 - Manoj Krishna Reddy
    Detailed Overview Of Granules India - Tushar Bohra
    Quick Walkthrough Of Granules - Tushar Bohra
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline